Literature DB >> 19002981

Large scale transient 5-HT3 receptor production with the Semliki Forest Virus Expression System.

H D Blasey1, B Brethon, R Hovius, H Vogel H, A P Tairi, K Lundström, L Rey, A R Bernard.   

Abstract

The expression of recombinant proteins with the Semliki Forest Virus (SFV) system has been scaled up to bioreactor scale. As a model protein for this study the human 5-HT(3) receptor was chosen. The gene for the receptor was subcloned into the SFV expression plasmid pSFV1. Virus production by in vivo packaging and production of the recombinant protein was scaled up, the latter to a reactor volume of 11.5 l. A Vibromix(TM) agitation system was chosen to overcome aggregation problems of BHK cells in suspension. In the process, cells were first grown to a density of 10(6) cells/ml, the medium was then exchanged with fresh medium and the culture was infected with the recombinant virus at an estimated multiplicity of infection of 30. 24 h post infection we measured an expression level of 3 million functional 5-HT(3) receptors per cell. For harvesting, the cells were pelleted by centrifugation. The receptor protein was purified in a single step (Hovius et al., 1998) by exploiting the hexa-His tag at minimal protein loss (51% yield). Experiments to optimise expression resulted in yields up to 8 million receptors per cell, when the pH of a suspension culture was controlled at pH 7.3. Rapid virus generation and protein production, high protein yields as well as successful large scale application have made the SFV expression system attractive to produce large quantities of recombinant protein in a very short time. After optimisation of the expression conditions (in particular by setting the pH at 7.3), yields were increased twofold.

Entities:  

Year:  2000        PMID: 19002981      PMCID: PMC3449892          DOI: 10.1023/A:1008192709549

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  59 in total

1.  Large scale transient expression with COS cells.

Authors:  H D Blasey; J P Aubry; G J Mazzei; A R Bernard
Journal:  Cytotechnology       Date:  1995-01       Impact factor: 2.058

2.  Characterization of a mouse serotonin 5-HT3 receptor purified from mammalian cells.

Authors:  R Hovius; A P Tairi; H Blasey; A Bernard; K Lundström; H Vogel
Journal:  J Neurochem       Date:  1998-02       Impact factor: 5.372

3.  Incorporation of homologous and heterologous proteins into the envelope of Moloney murine leukemia virus.

Authors:  M Suomalainen; H Garoff
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

4.  Enhancing immune responses using suicidal DNA vaccines.

Authors:  P Berglund; C Smerdou; M N Fleeton; I Tubulekas; P Liljeström
Journal:  Nat Biotechnol       Date:  1998-06       Impact factor: 54.908

5.  Two-helper RNA system for production of recombinant Semliki forest virus particles.

Authors:  C Smerdou; P Liljeström
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

6.  Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular forms.

Authors:  P Mikus; T Urano; P Liljeström; T Ny
Journal:  Eur J Biochem       Date:  1993-12-15

7.  A significantly improved Semliki Forest virus expression system based on translation enhancer segments from the viral capsid gene.

Authors:  E M Sjöberg; M Suomalainen; H Garoff
Journal:  Biotechnology (N Y)       Date:  1994-11

8.  Expression and analysis of presenilin 1 in a human neuronal system: localization in cell bodies and dendrites.

Authors:  D G Cook; J C Sung; T E Golde; K M Felsenstein; B S Wojczyk; R E Tanzi; J Q Trojanowski; V M Lee; R W Doms
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

9.  Production of intracellular amyloid-containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence.

Authors:  B De Strooper; M Simons; G Multhaup; F Van Leuven; K Beyreuther; C G Dotti
Journal:  EMBO J       Date:  1995-10-16       Impact factor: 11.598

10.  Expression analysis of recombinant herpes simplex virus type 1 DNase.

Authors:  E Kehm; M A Göksu; C W Knopf
Journal:  Virus Genes       Date:  1998       Impact factor: 2.198

View more
  3 in total

1.  High yield and efficient expression and purification of the human 5-HT3A receptor.

Authors:  Zhong-shan Wu; Zhi-cheng Cui; Hao Cheng; Chen Fan; Karsten Melcher; Yi Jiang; Cheng-hai Zhang; Hua-Liang Jiang; Yao Cong; Qian Liu; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2015-06-15       Impact factor: 6.150

2.  Hydrophobic photolabeling studies identify the lipid-protein interface of the 5-HT3A receptor.

Authors:  Mitesh Sanghvi; Ayman K Hamouda; Margaret I Davis; Russell A Morton; Shouryadeep Srivastava; Akash Pandhare; Phaneendra K Duddempudi; Tina K Machu; David M Lovinger; Jonathan B Cohen; Michael P Blanton
Journal:  Biochemistry       Date:  2009-10-06       Impact factor: 3.162

Review 3.  Viral and Synthetic RNA Vector Technologies and Applications.

Authors:  Juliane W Schott; Michael Morgan; Melanie Galla; Axel Schambach
Journal:  Mol Ther       Date:  2016-07-05       Impact factor: 11.454

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.